TP53 and neoplasm: For example, in transgenic mouse models, augmenting the endogenous p53 activity with a truncated form of p53 or an extra copy of wild-type, full-length p53 transgene enhanced resistance to spontaneous tumor development (García-Cao et al., 2002; Tyner et al., 2002).